Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (7)
  • 2024 (10)
  • 2023 (7)
  • 2022 (9)

Subject

  • Drug Trafficking (281)
  • OCDETF/Task Force (92)
  • Guns/Weapons (75)
  • Fake Pills (27)
  • HIDTA (7)
  • Prescription Drugs (7)
  • Money Laundering (6)
  • Gangs (2)
  • Guilty Plea (2)
  • Diversion Division (7)

Drug Name

  • Fentanyl (2)
  • Opioids (2)
  • Benzodiazepines (1)
  • Hydromorphone (1)
  • Morphine (1)

Field Division

  • New York (11)
  • Chicago (8)
  • Washington, DC (8)
  • Houston (7)
  • Atlanta (5)
  • Seattle (5)
  • New Jersey (4)
  • New Orleans (4)
  • Miami (3)
  • Rocky Mountain (3)
  • San Francisco (2)
  • St. Louis (2)
  • Dallas (1)
  • Louisville (1)
  • Phoenix (1)
  • Sede (1)
  • New England (7)
Clear All Results
PRESS RELEASE

Two Former Nurses Indicted in Connection to the Diversion of Dangerous Narcotics by Medical Professionals

Diciembre 11, 2023
CONCORD, N.H. – A Newbury woman and Northfield woman, two former nurses, were indicted in connection to the diversion of dangerous narcotics by medical professionals, U.S. Attorney Jane E. Young announces. Robin Nichols, 63, of Newbury, was indicted on one count of Tampering with Consumer Products and one count of...
Diciembre 11, 2023
PRESS RELEASE

Former Nurse Sentenced for Drug Diversion from Boston-Area Hospital

Noviembre 15, 2023
BOSTON – A former nurse was sentenced yesterday in federal court today in Boston for diverting opioids from a Boston-area hospital. Andrea Falzano, 39, of Winchester, was sentenced by U.S. District Court Judge Nathaniel M. Gorton to three months in prison and one year of supervised release. In August 2023...
Noviembre 15, 2023
PRESS RELEASE

New Hampshire Doctor Indicted for Unlawfully Distributing Opioids and Benzodiazepines

Septiembre 19, 2023
CONCORD, N.H. – A doctor practicing in the north country of New Hampshire was indicted in connection with his unlawful distribution of opioids and benzodiazepines, U.S. Attorney Jane E. Young announces. Robert G. Soucy Jr., D.O., 70, of Columbia, New Hampshire, was indicted on 12 counts of distribution of controlled...
Septiembre 19, 2023
PRESS RELEASE

Health Care Company and Cheshire Pharmacy Pay $500K to Resolve Controlled Substances Act Allegations

Agosto 31, 2023
CHESHIRE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration for New England, announced that Clarest, LLC, doing business as Clarest Health, ProCare LTC New England LTC, and ProCare LTC Pharmacy of Connecticut LLC...
Agosto 31, 2023
PRESS RELEASE

CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions

Junio 26, 2023
CONCORD, N.H. – CVS has agreed to pay $70,000 to resolve allegations that it violated the Controlled Substances Act at CVS stores in New Hampshire, U.S. Attorney Jane E. Young announces. “Pharmacies have a legal responsibility to ensure that controlled substances are dispensed only pursuant to valid prescriptions,” said United...
Junio 26, 2023
PRESS RELEASE

Cheshire Medical Center to Pay $2 Million to Settle Allegations of Controlled Substances Act Violations

Junio 22, 2023
CONCORD, N.H. – U.S. Attorney Jane E. Young announces today that Cheshire Medical Center (CMC) in Keene will pay $2 million to resolve allegations that it violated the Controlled Substances Act (CSA) by failing to keep accurate records of controlled substances, including opioids. “Cheshire Medical Center’s failure to fulfill its...
Junio 22, 2023
PRESS RELEASE

Former Nurse Indicted for Drug Diversion from Boston Hospital

Febrero 27, 2023
BOSTON – A former nurse has been indicted by a federal grand jury in Boston for allegedly diverting opioids from a Boston-area hospital. Andrea Falzano, 38, of Winchester, was indicted on three counts of unlawfully obtaining controlled substances by fraud, deception and subterfuge. Falzano was arrested this morning and will...
Febrero 27, 2023
Showing 1 - 7 of 7 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster